Gathering genetic information to improve coronary artery disease risk prediction

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Genetics and Vascular Health Check study (GENVASC) aims to determine if genetic information can enhance the prediction of Coronary Artery Disease (CAD) risk. Conducted in collaboration with Clinical Commissioning Groups and Primary Care practices in Leicester, Leicestershire, and Northamptonshire, this observational study seeks to refine current risk categorization methods. By analyzing genetic variants alongside traditional demographic and lifestyle factors, the study hopes to identify individuals at risk more accurately, particularly those in low and medium risk categories who may benefit from targeted prevention strategies.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male and female patients who are eligible for an NHS Health Check
* Aged between 40 and 74 years of age
* Able to provide informed consent

Exclusion Criteria:

* History of preexisting cardiovascular disease
* History of blood borne infection (such as HIV, Hepatitis B)
* Unable to provide informed consent

Where it's running

• Primary Care, LLR and Northamptonshire
  Leicester, United Kingdom Recruiting

Study contacts

• Study coordinator: Emma P Beeston
• Email: epb2@leicester.ac.uk
• Phone: 0116 204 4738

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery

  This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07870941

• AI-powered ECG to help diagnose and predict outcomes in heart disease

  Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07856472

• Colchicine for preventing cardiovascular disease in adults with type 2 diabetes

  A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.

  Recruiting Phase 2 Tan Tock Seng Hospital · Singapore, Singapore · NCT07837934

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

• One-stop photon-counting CT for patients after PCI

  This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07763340

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.